Taiwan FDA registration edbf49fd5f2609fb043f976c65c6f5b3
Apex multiple drug concentration qualitative correction solution
TW: 亞培多重藥物濃度定性校正液
Taiwan·Risk Class 2·MICROGENICS CORPORATION·Registered Nov 09, 2020 – Nov 09, 2025ExpiredRegistration details
- Analysis ID
- edbf49fd5f2609fb043f976c65c6f5b3
- Customs Code
- DHA05603415201
Company information
- Manufacturer
- MICROGENICS CORPORATION
- Manufacturer Country
- United States
- Authorized Representative
- ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.)
Product details
- Intended Use
- This product is used with Alinity c analyzer to correct benzidazolith serum analysis and tricyclic antidepressant analysis.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.3200 Clinical Toxicology Corrector
- Import Information
- QMS/QSD;; 輸入
Dates and status
- Registration Date
- Nov 09, 2020
- Expiry Date
- Nov 09, 2025
About this record
Access comprehensive regulatory information for Apex multiple drug concentration qualitative correction solution in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number edbf49fd5f2609fb043f976c65c6f5b3 and manufactured by MICROGENICS CORPORATION. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices